Text Size

First Experimental Study of Transference Work - In Teenagers (FEST-IT)

This study is currently recruiting participants.
Verified February 2012 by Sykehuset i Vestfold HF
Sponsor:
Collaborator:
University of Oslo
Information provided by (Responsible Party):
Randi Ulberg, Sykehuset i Vestfold HF
ClinicalTrials.gov Identifier:
NCT01531101
First received: February 8, 2012
Last updated: February 9, 2012
Last verified: February 2012
History of Changes
  Purpose

The First Experimental Study on Transference work - In Teenagers (FEST-IT) will be a randomized clinical trial, which will be designed to explore effects of transference work in dynamic psychotherapy in adolescents with MDD. The design of the study is a so-called dismantling design, in which a single component is added and/or varied to an existent treatment method (psychodynamic psychotherapy). Thus, the efficiency of a specific technique (transference interventions) can be identified.

The primary hypothesis is that the transference group may have a more favorable course over time than will the comparison group.

The second hypothesis is that patients with a history of low Quality of Object Relations score and/or lacking personality disorders—might benefit more from therapy with transference work than from therapy without.

The third hypothesis is that female adolescents may have better treatment effect of transference work than male adolescents.


Condition Intervention Phase
Psychodynamic
Depression
 Behavioral: Individual therapy
Other: Psychotherapy
 Phase 2

Study Type: Interventional
Study Design: Primary Purpose: Treatment

Resource links provided by NLM:

MedlinePlus related topics: Depression
U.S. FDA Resources

Further study details as provided by Sykehuset i Vestfold HF:

Primary Outcome Measures:
  • Psychodynamic Functioning Scales (PFS)
  • Inventory of Interpersonal Problems-Circumplex Version (IIP-C)

Secondary Outcome Measures:
  • Global Assessment of Functioning (GAF)
  • Symptom Checklist-90 (Global Severity Index; GSI)
  • Beck Depression Inventory (BDI)
  • Montgomery Åsberg Rating Scale (MADRS)

Study Start Date: January 2012
Estimated Study Completion Date: September 2028
Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Transference work Behavioral: Individual therapy Other: Psychotherapy

  Eligibility

Ages Eligible for Study:   16 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adolescents aged 16 - 18 years

Exclusion Criteria:

  • Pervasive developmental disorder,
  • psychosis, or substance abuse
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01531101

Contacts
Contact: Randi Ulberg, PhD + 47 22 02 99 77 Randi.Ulberg@siv.no
Contact: Anne Hersoug, Dr.Phil. + 47 22 02 99 77 A.G.Hersoug@medisin.uio.no

Locations
Norway
Research Unit, Division of Recruiting
Tønsberg, Vestfold, Norway, 3103
Contact: Randi Ulberg, PhD            
Principal Investigator: Randi Ulberg, PhD            
Sub-Investigator: Anne Hersoug, Dr.Phil            
Sub-Investigator: Per Høglend, Dr.med            
Sponsors and Collaborators
Randi Ulberg
University of Oslo
  More Information

Additional Information:
The Central Norway Regional Ethics Health Committee  This link exits the ClinicalTrials.gov site
Sykehuset i Vesthold  This link exits the ClinicalTrials.gov site
University of Oslo  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Randi Ulberg, Researcher, Sykehuset i Vestfold HF
ClinicalTrials.gov Identifier: NCT01531101     History of Changes
Other Study ID Numbers: Sykehuset i Vestfold, REK: 2011/1424 FEST-IT
Study First Received: February 8, 2012
Last Updated: February 9, 2012
Health Authority: Norway: Regionale komiteer for medisinsk og helsefaglig forskningsetikk

Keywords provided by Sykehuset i Vestfold HF:
Transference work
Psychodynamic
Depression
Treatment
Adolescent

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 21, 2013